Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VK2735 in obesity and overweight with comorbidities
NCT07104500Phase 3Active, not recruiting
- Sponsor
- Viking Therapeutics
- Start
- Jun 2025
- Primary completion
- Jul 2027
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of VK-2735 in obesity, sponsored by Viking Therapeutics. Started Jun 2025; status: active, not recruiting.
02
Drugs
VK-2735
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07104500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07104500.